journal
https://read.qxmd.com/read/37231563/factors-affecting-presenteeism-in-workers-with-nocturnal-hemodialysis-a-two-center-cross-sectional-study
#1
JOURNAL ARTICLE
Hiroki Yabe, Aki Tabata, Norihisa Sugimoto, Tomohiro Saeki, Takeshi Tsukada, Jin Mohara
INTRODUCTION: Presenteeism and work dysfunction in dialysis patients should be assessed to improve disease management and work productivity. Therefore, this study aimed to investigate the prevalence and factors surrounding presenteeism and work dysfunction in workers with nocturnal hemodialysis. METHODS: This multicenter cross-sectional study included 42 workers with nocturnal hemodialysis. Presenteeism was measured in patients using the Work Functioning Impairment Scale (WFun), employment status, exercise habit, and exercise self-efficacy (SE)...
May 25, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37217295/management-of-dialysis-patients-with-hepatitis-c-virus-in-the-era-of-direct-acting-antiviral-therapy
#2
REVIEW
Hidenori Toyoda, Kan Kikuchi
The clinical use of direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection has dramatically changed management of patients with HCV liver disease since 2014; this is also true for patients undergoing dialysis. Due to the high tolerability and antiviral efficacy of anti-HCV therapy, most dialysis patients with HCV infection should currently be candidates for this treatment. Many patients with HCV antibodies no longer have HCV infection, and it is difficult to identify patients with actual HCV infection based only on HCV antibody assays...
May 22, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37217275/autoantibodies-in-covid-19-a-possible-role-in-the-pathogenesis-of-the-disease
#3
JOURNAL ARTICLE
Nikolina Basic-Jukic, Gordana Pavlisa, Nada Tomic Sremec, Ivana Juric, Robert Ledenko, Dunja Rogic, Bojan Jelakovic
OBJECTIVES: In this study, we investigated whether SARS-CoV-2 stimulates autoantibody production. METHODS: The study included 91 patients hospitalized due to COVID 19, with no previous history of immunological diseases. Immunofluorescence assays were performed to detect antinuclear antibodies (ANAs) and antineutrophil cytoplasmic antibodies (ANCAs), along with tests for specific autoantibodies. RESULTS: The median age (57% male) was 74 years (range 38-95 years)...
May 22, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37211527/impact-of-therapeutic-and-low-volume-plasma-exchange-on-clinical-laboratory-parameters-in-patients-treated-for-alzheimer-s-disease-from-the-ambar-study
#4
JOURNAL ARTICLE
Carlota Grifols, Miquel Barceló, Laura Núñez, Zbigniew M Szczepiorkowski, Mercè Boada, Oscar L López, Antonio Páez
INTRODUCTION: Little is known about the impact of plasma exchange (PE) on clinical laboratory parameters in Alzheimer's disease (AD) patients. METHODS: AD patients in the AMBAR trial (N = 322) received weekly therapeutic PE (TPE) for 6 weeks followed by monthly low-volume PE (LVPE) for12 months. Treatment were placebo (sham PE), low-albumin, low-albumin + IVIG (i.e., albumin alternated with intravenous immunoglobulin) and high-albumin + IVIG...
May 21, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37177852/evaluation-of-clinical-features-and-laboratory-findings-in-critical-intensive-care-unit-patients-with-severe-coronavirus-disease-19-who-underwent-extracorporeal-cytokine-adsorption
#5
JOURNAL ARTICLE
Tunzala Yavuz, Semiha Orhan, Kazim Rollas, Cansu Koseoglu Toksoy, Elif Dizen Kazan, Erhan Bozkurt, İbrahim Guven Cosgun, Filiz Yavasoglu
AIM: To evaluate the inflammatory parameters and oxygenation in severe coronavirus disease-19 patients who underwent extracorporeal cytokine adsorption (CA). METHODS: Patients who underwent extracorporeal CA for cytokine storm were included in the study. The changes in oxygenation, laboratory parameters, and mortality rates were investigated. RESULTS: Thirty-six patients were included in the study. The hemoglobin, thrombocyte, and C-reactive protein (CRP) decreased, and PaO2 /FiO2 ratio increased (p < 0...
May 12, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37165304/the-effect-of-refined-nursing-education-on-improving-the-urination-of-patients-after-renal-biopsy
#6
JOURNAL ARTICLE
Hailing Wang, Xiaodong Xie, Na Li, Liying Zhu
BACKGROUND: To investigate the clinical effect of better nursing education on patients' postoperative urination after renal biopsy. METHODS: In this study, patients who underwent renal biopsy in the Department of Nephrology at our hospital were selected as the observation group (July-December 2018, n = 120) and control group (January-June 2018, n = 110) and received refined nursing education and routine nursing education, respectively...
May 10, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37137698/optimizing-peritoneal-dialysis-initiation-a-comparative-cohort-study-of-catheter-placement-methods-for-shortening-break-in-periods
#7
JOURNAL ARTICLE
Hugo E Chávez-Chávez, Elisa Naomi Hernández-Paredes, Gabriel Cojuc-Konigsberg, Cecilia Vargas-Rodríguez, Laura Margarita Díaz-Canchola, Octavio Vergara-Zavala, Alonso Fernández-Venegas, Nadia Stephani Acevedo-Juárez, Ricardo Correa-Rotter, Juan C Ramirez-Sandoval
INTRODUCTION: Peritoneal dialysis (PD) guidelines recommend a 14-day break-in period after catheter placement, yet this period could be shortened with new insertion techniques. METHODS: We conducted a prospective cohort study to compare percutaneous vs. surgical catheter insertion in a newly established PD program. The break-in period was intentionally shortened to <24 h to start PD almost immediately. RESULTS: We included 223 subjects who underwent percutaneous (34%) or surgical (66%) catheter placement...
May 3, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37125473/current-elimination-status-of-hepatitis-c-virus-infected-maintenance-hemodialysis-patients-in-iwate-prefecture-japan
#8
JOURNAL ARTICLE
Akio Miyasaka, Yuichi Yoshida, Akiko Suzuki, Kei Endo, Keisuke Kakisaka, Takayoshi Oikawa, Takaya Abe, Wataru Obara, Takayuki Matsumoto
INTRODUCTION: The aim is to clarify the hepatitis C virus (HCV) status of hemodialysis (HD) patients and patient management after HCV elimination. METHODS: Questionnaire survey was conducted in Iwate prefecture, Japan from 2016 to 2021. RESULTS: Patients underwent HD was 2944, including 132 anti-HCV antibody-positive patients, with 91 HCV RNA-positive patients. Of the 91 HCV RNA-positive patients, 51 received antiviral treatment. Sustained virological response (SVR) rate was 94%...
May 1, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37115023/analysis-of-the-impact-of-peritoneal-dialysis-catheter-tail-end-design-on-catheter-related-complications
#9
JOURNAL ARTICLE
Hong-Chang Zou, Ming-Ming Gao, Yan-Xia Chen, Cheng-Yun Xu, Wei-Ping Tu, Xiao-Hua Qin
OBJECTIVE: Evaluate the impact of peritoneal dialysis catheter (PDC) tail-end design variations on PDC-related complications. METHOD: Effective data were extracted from databases. The literature was evaluated according to the Cochrane Handbook for Systematic Reviews of Interventions, and a meta-analysis was conducted. RESULTS: Analysis revealed that the straight-tailed catheter was superior to the curled-tailed catheter in minimizing catheter displacement and complication-induced catheter removal (RR = 1...
April 28, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37082860/trapped-lung-and-refractory-pleural-effusion-in-a-patient-receiving-peritoneal-dialysis
#10
LETTER
Yuya Sato, Yusuke Takahashi, Kazuyuki Tasaki
No abstract text is available yet for this article.
April 21, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37073104/successful-pregnancy-in-a-hemodialysis-patient-with-primary-hyperoxaluria-type-1
#11
LETTER
Franka Zuban, Ranko Ladavac, Nikolina Basic-Jukic
No abstract text is available yet for this article.
April 18, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37070658/severe-posthemodialysis-thrombocytopenia-what-if-it-s-not-the-heparin
#12
LETTER
Leonidas Cruzado Vega, Juan P Moret Chiappe, Alba Santos García
No abstract text is available yet for this article.
April 18, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37056201/clinical-impact-of-a-novel-lipoprotein-apheresis-treatment-on-no-option-chronic-limb-threatening-ischemia-result-from-the-reduction-viscosity-study
#13
JOURNAL ARTICLE
Shunsuke Kojima, Tatsuya Nakama, Toshihiko Suzuki, Kotaro Obunai, Hiroyuki Watanabe
INTRODUCTION: Lipoprotein apheresis (LA) is a possible adjunct treatment for no-option chronic limb-threatening ischemia (CLTI). This study aimed to assess the impact of a novel LA for no-option CLTI. METHODS: We retrospectively assessed 19 patients with no-option CLTI treated using the novel LA. The primary outcome was a change in the skin perfusion pressure (SPP) after treatment with LA, and the secondary outcomes were changes in the viscosity-related laboratory parameters...
April 13, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37055380/impact-of-covid-19-on-maintenance-peritoneal-dialysis-patients-and-providers-a-review
#14
REVIEW
David F Painter, Braden Vogt, Anagha Lokhande, Rodrigo Saad Berreta, Ankur D Shah
The COVID-19 pandemic exerted complex pressures on the nephrology community. Despite multiple prior reviews on acute peritoneal dialysis during the pandemic, the effects of COVID-19 on maintenance peritoneal dialysis patients remain underexamined. This review synthesizes and reports findings from 29 total cases of chronic peritoneal dialysis patients with COVID-19, encompassing 3 case reports, 13 case series, and 13 cohort studies. When available, data for patients with COVID-19 on maintenance hemodialysis are also discussed...
April 13, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37052040/influence-of-dialysis-related-stigma-on-health-related-indicators-in-japanese-patients-undergoing-hemodialysis
#15
JOURNAL ARTICLE
Hidehiro Sugisawa, Yumiko Shimizu, Tamaki Kumagai, Kanji Shishido, Yutaka Koda, Toshio Shinoda
INTRODUCTION: Focusing on impacts to health-related indicators in older Japanese patients, this study analyzed both the direct influence of dialysis-related stigma and influences of its intersectionality with other stigmatized characteristics. METHODS: Data were collected through a cross-sectional survey of 7461 outpatients in dialysis facilities. Other stigmatized characteristics include lower income, lower education, disabled activities of daily living, and diabetic end-stage renal disease (ESRD) as a cause for starting dialysis treatment...
April 13, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37042084/correction-to-prostacyclin-analog-beraprost-sodium-efficacy-in-primary-glomerular-disease-or-nephrosclerosis-analysis-of-the-japanese-subgroup-in-cassiopeir-study
#16
(no author information available yet)
No abstract text is available yet for this article.
April 11, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37039816/the-effect-of-the-time-from-diagnosis-to-induction-therapy-on-prognosis-in-patients-with-acute-leukemia-undergoing-leukapheresis-for-symptomatic-hyperleukocytosis
#17
JOURNAL ARTICLE
İbrahim Ethem Pınar, Vildan Özkocaman, Tuba Ersal, Mehmet Emin Dağtekin, Cumali Yalçın, Bedrettin Orhan, Ömer Candar, Sinem Çubukçu, Tuba Güllü Koca, Vildan Gürsoy, Fahir Özkalemkaş
INTRODUCTION: Our study investigated leukapheresis's effect on delayed induction therapy outcomes in patients with acute leukemia presenting with symptomatic hyperleukocytosis. METHODS: This retrospective cohort study included 30 adult patients diagnosed with acute leukemia who underwent leukapheresis for leukostasis. The patients were divided into the first 24 h and >24 h groups, according to the time from diagnosis to induction therapy (TDT). RESULTS: There was no significant difference between the TDT groups regarding complete remission (CR), 4-week mortality, and overall survival (OS) at a median follow-up of 409 days...
April 11, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37039771/a-novel-device-and-system-concept-for-therapeutic-plasma-exchange-in-rats
#18
JOURNAL ARTICLE
Mitică Ciorpac, Cezar-Cătălin Caratașu, Andrei Szilagyi, Cosmin-Teodor Mihai, Ionut Nistor, Radu Iliescu, Bogdan Ionel Tamba
INTRODUCTION: Therapeutic plasma exchange (TPE) has been developed more than 100 years ago in an animal model and adapted to humans 30 years later. Since then, the TPE research on animal models is lacking, mainly due to difficulties raised by the scaling of the plasmapheresis unit so that the animal's cardiovascular parameters are not considerably affected. METHODS: The system concept of a novel TPE device with continuous hemodynamic monitoring in small rodent models has been used...
April 11, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37039703/comparison-the-effect-of-valerian-and-gabapentin-on-rls-and-sleep-quality-in-hemodialysis-patients-a-randomized-clinical-trial
#19
JOURNAL ARTICLE
Iman Hajizadeh, Mahdieh Jamshidi, Majid Kazemi, Hossein Kargar, Tabandeh Sadeghi
INTRODUCTION: This study aimed to compare the effect of valerian and gabapentin on restless legs syndrome (RLS) and sleep quality in HD patients. METHODS: In this cross over clinical trial study, 40 HD patients allocated into a valerian and gabapentin group. In the first phase of the study, Group A received valerian and Group B received gabapentin 1 h before bedtime for 1 month. In the second phase, the two groups' treatment regimen was swapped. After a 1-month washout period, the same process was repeated on the crossover groups...
April 11, 2023: Therapeutic Apheresis and Dialysis
https://read.qxmd.com/read/37028928/effect-of-ramadan-fasting-on-chronic-inflammation-markers-and-gut-bacterial-endotoxins-among-egyptian-hemodialysis-patients
#20
JOURNAL ARTICLE
Emad Samaan, Ahmed A Eldeeb, Ahmed B Ibrahim, Mohammed Erman, Alaa A Sabry, Mostafa A Mahmoud
BACKGROUND: Chronic kidney disease (CKD) is associated with a state of chronic inflammation. This study aimed to investigate effects of Ramadan fasting on the markers of chronic inflammation and gut bacterial endotoxin levels in maintenance hemodialysis. METHOD: A prospective self-controlled observational study included 45 patients. Serum levels of High Sensitive CRP (hsCRP), indoxyl sulfate, and trimethylamine-n-levels were measured within a week before and a week after Ramadan fasting...
April 7, 2023: Therapeutic Apheresis and Dialysis
journal
journal
40470
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.